Journal
JOURNAL OF LAW MEDICINE & ETHICS
Volume 44, Issue 2, Pages 231-240Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1073110516654133
Keywords
-
Categories
Funding
- NICHD NIH HHS [R01 HD073292] Funding Source: Medline
Ask authors/readers for more resources
Newborn screening has evolved to include an increasingly complex spectrum of diseases, raising concerns that screening should be optional and require parental consent. Early detection of disorders like PKU and MCAD is essential to prevent serious disability and death in affected children. These are examples of high benefit-risk ratio disorders because of the irrefutable health benefits of early detection, coupled with the low risks of treatment. The dire consequences of not diagnosing an infant with a treatable disorder because of parental refusal to screen are wholly unacceptable. Thus, we believe that newborn screening for disorders with high benefit-risk ratios should continue to be mandatory.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available